Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
Saved in:
| Title: | Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B. |
|---|---|
| Authors: | Daemen A; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America., Udyavar AR; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America., Sandmann T; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America., Li C; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Bosch LJW; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., O'Gorman W; OMNI Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Li Y; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Au-Yeung A; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Takahashi C; OMNI Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Kabbarah O; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Bourgon R; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America., Hegde P; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Bais C; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Das Thakur M; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America. |
| Source: | PloS one [PLoS One] 2021 Dec 31; Vol. 16 (12), pp. e0262198. Date of Electronic Publication: 2021 Dec 31 (Print Publication: 2021). |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34972191 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Daemen+A%22">Daemen A</searchLink>; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Udyavar+AR%22">Udyavar AR</searchLink>; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Sandmann+T%22">Sandmann T</searchLink>; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Bosch+LJW%22">Bosch LJW</searchLink>; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22O'Gorman+W%22">O'Gorman W</searchLink>; OMNI Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Au-Yeung+A%22">Au-Yeung A</searchLink>; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Takahashi+C%22">Takahashi C</searchLink>; OMNI Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Kabbarah+O%22">Kabbarah O</searchLink>; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Bourgon+R%22">Bourgon R</searchLink>; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Hegde+P%22">Hegde P</searchLink>; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Bais+C%22">Bais C</searchLink>; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Das+Thakur+M%22">Das Thakur M</searchLink>; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2021 Dec 31; Vol. 16 (12), pp. e0262198. <i>Date of Electronic Publication: </i>2021 Dec 31 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34972191 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0262198 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0262198 Titles: – TitleFull: Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Daemen A – PersonEntity: Name: NameFull: Udyavar AR – PersonEntity: Name: NameFull: Sandmann T – PersonEntity: Name: NameFull: Li C – PersonEntity: Name: NameFull: Bosch LJW – PersonEntity: Name: NameFull: O'Gorman W – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Au-Yeung A – PersonEntity: Name: NameFull: Takahashi C – PersonEntity: Name: NameFull: Kabbarah O – PersonEntity: Name: NameFull: Bourgon R – PersonEntity: Name: NameFull: Hegde P – PersonEntity: Name: NameFull: Bais C – PersonEntity: Name: NameFull: Das Thakur M IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 12 Text: 2021 Dec 31 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 16 – Type: issue Value: 12 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |